Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 31.63% is 1630% above its 5-year average of 1.83%, near the high end of its 5-year range (0.86%–31.63%).
As of the fiscal period ended Tuesday, June 30, 2026. 98.72% above its 12-month average of 15.92%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 31.63%.
DEBT TO ASSETS RATIO
31.63%
DEBT TO ASSETS RATIO AVG TTM
15.92%
DEBT TO ASSETS RATIO AVG 3Y
2.28%
DEBT TO ASSETS RATIO AVG 5Y
1.83%
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+98.72%
CURRENT VS 3Y AVG
+1285.36%
CURRENT VS 5Y AVG
+1630.38%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.10%
median of 725 covered companies
CURRENT VS SECTOR MEDIAN
+31531.43%
vs the sector median at left
Lifeward Ltd.
Market Cap
$10.57M
Debt to Assets Ratio
31.63%
TTM Avg
15.92%
3Y Avg
2.28%
5Y Avg
1.83%
Market Cap
$10.52M
Debt to Assets Ratio
0.06%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$10.68M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$10.43M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$10.84M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$10.06M
Debt to Assets Ratio
0.80%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Lifeward Ltd. (LFWD) | $10.57M | 31.63% | 15.92% | 2.28% | 1.83% |
| Polyrizon Ltd. (PLRZ)vs › | $10.53M | 0.00% | N/A | N/A | N/A |
| CytoMed Therapeutics Limited (GDTC)vs › | $10.52M | 0.06% | N/A | N/A | N/A |
| Caring Brands, Inc. (CABR)vs › | $10.68M | 0.00% | N/A | N/A | N/A |
| Satellos Bioscience Inc. (MSLE)vs › | $10.43M | 0.00% | N/A | N/A | N/A |
| Lisata Therapeutics, Inc. (LSTA)vs › | $10.84M | 0.00% | N/A | N/A | N/A |
| Cerenome, Inc. (CNSY)vs › | $11.08M | 0.00% | N/A | N/A | N/A |
| BioVie Inc. (BIVI)vs › | $11.08M | 0.02% | N/A | N/A | N/A |
| Medicus Pharma Ltd. Common Stock (MDCX)vs › | $10.06M | 0.80% | N/A | N/A | N/A |
| NeuroOne Medical Technologies Corporation (NMTC)vs › | $10.01M | 0.01% | N/A | N/A | N/A |
Debt/Assets
31.6%
Debt/Equity
0.91
Current Ratio
2.33
Interest Coverage
-57.3x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 31.63% |
| 2026-03-31 | 26.37% |
| 2025-12-31 | 19.16% |
| 2025-09-30 | 1.02% |
| 2025-06-30 | 1.40% |
| 2025-03-31 | 2.15% |
| 2024-12-31 | 2.89% |
| 2024-09-30 | 2.14% |
| 2024-06-30 | 2.53% |
| 2024-03-31 | 2.90% |
| 2023-12-31 | 3.01% |
| 2023-09-30 | 3.04% |
| 2023-06-30 | 1.76% |
| 2023-03-31 | 1.86% |
| 2022-12-31 | 1.21% |
| 2022-09-30 | 0.86% |
| 2022-06-30 | 0.95% |
| 2022-03-31 | 1.08% |
| 2021-12-31 | 1.12% |
| 2021-09-30 | 1.19% |
| 2021-06-30 | 1.82% |
